• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绘制血管内皮生长因子/胎盘生长因子受体Flt-1第二个免疫球蛋白样结构域中结合和结构稳定性所需的带电残基图谱。

Mapping the charged residues in the second immunoglobulin-like domain of the vascular endothelial growth factor/placenta growth factor receptor Flt-1 required for binding and structural stability.

作者信息

Davis-Smyth T, Presta L G, Ferrara N

机构信息

Departments of Cardiovascular Research, Genentech, Inc., South San Francisco, California 94080, USA.

出版信息

J Biol Chem. 1998 Feb 6;273(6):3216-22. doi: 10.1074/jbc.273.6.3216.

DOI:10.1074/jbc.273.6.3216
PMID:9452434
Abstract

Flt-1 is one of two receptor tyrosine kinases through which the angiogenic factor vascular endothelial growth factor (VEGF) functions. Placenta growth factor (PlGF) is an additional ligand for Flt-1. The second immunoglobulin-like domain in the extracellular domain of Flt-1 has previously been identified as the region containing the critical ligand-binding determinants. We analyzed the contribution of charged residues within the first three domains of Flt-1 to ligand binding by alanine-scanning mutagenesis. Domain 2 residues Arg159, Glu208 and His223-Arg224 (together) affect both VEGF and PlGF binding, while Glu137, Lys171, His223, and Arg224 affect PlGF but not VEGF. Several charged residues, especially Asp187, are important in maintaining the structural integrity of domain 2. In addition, some residues in domain 3 contribute to binding (Asp231) or provide for additional discrimination between ligands (Arg280-Asp283).

摘要

Flt-1是血管生成因子血管内皮生长因子(VEGF)发挥作用的两种受体酪氨酸激酶之一。胎盘生长因子(PlGF)是Flt-1的另一种配体。Flt-1胞外结构域中的第二个免疫球蛋白样结构域先前已被确定为包含关键配体结合决定簇的区域。我们通过丙氨酸扫描诱变分析了Flt-1前三个结构域中带电荷残基对配体结合的贡献。结构域2中的残基Arg159、Glu208和His223-Arg224(共同作用)影响VEGF和PlGF的结合,而Glu137、Lys171、His223和Arg224影响PlGF但不影响VEGF。几个带电荷残基,尤其是Asp187,对维持结构域2的结构完整性很重要。此外,结构域3中的一些残基有助于结合(Asp231)或在配体之间提供额外的区分(Arg280-Asp283)。

相似文献

1
Mapping the charged residues in the second immunoglobulin-like domain of the vascular endothelial growth factor/placenta growth factor receptor Flt-1 required for binding and structural stability.绘制血管内皮生长因子/胎盘生长因子受体Flt-1第二个免疫球蛋白样结构域中结合和结构稳定性所需的带电残基图谱。
J Biol Chem. 1998 Feb 6;273(6):3216-22. doi: 10.1074/jbc.273.6.3216.
2
Solution structure of the VEGF-binding domain of Flt-1: comparison of its free and bound states.Flt-1的VEGF结合域的溶液结构:其游离态与结合态的比较。
J Mol Biol. 1999 Oct 29;293(3):531-44. doi: 10.1006/jmbi.1999.3134.
3
Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor.血管内皮生长因子(VEGF)与Flt-1受体结构域2复合物的1.7埃分辨率晶体结构。
Cell. 1997 Nov 28;91(5):695-704. doi: 10.1016/s0092-8674(00)80456-0.
4
Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis.鉴定血管内皮生长因子与KDR和FLT-1受体结合的决定因素。通过定点诱变产生受体选择性VEGF变体。
J Biol Chem. 1996 Mar 8;271(10):5638-46. doi: 10.1074/jbc.271.10.5638.
5
Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor.一种噬菌体衍生肽拮抗剂与血管内皮生长因子复合物的溶液结构
J Mol Biol. 2002 Feb 22;316(3):769-87. doi: 10.1006/jmbi.2001.5370.
6
Characterization of the VEGF binding site on the Flt-1 receptor.Flt-1受体上血管内皮生长因子(VEGF)结合位点的特征分析
Biochem Biophys Res Commun. 1999 Sep 7;262(3):731-8. doi: 10.1006/bbrc.1999.1282.
7
Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1.血管内皮生长因子受体FLT-1胞外域配体结合位点及受体二聚化位点的定位
J Biol Chem. 1997 Apr 18;272(16):10382-8. doi: 10.1074/jbc.272.16.10382.
8
Characterization of the extracellular domain in vascular endothelial growth factor receptor-1 (Flt-1 tyrosine kinase).血管内皮生长因子受体-1(Flt-1酪氨酸激酶)细胞外结构域的特征分析
Jpn J Cancer Res. 1997 Sep;88(9):867-76. doi: 10.1111/j.1349-7006.1997.tb00463.x.
9
Vascular endothelial growth factor and its receptors in normal human testicular tissue.正常人类睾丸组织中的血管内皮生长因子及其受体
Mol Cell Endocrinol. 1997 Jul 4;131(1):9-20. doi: 10.1016/s0303-7207(97)00082-8.
10
The crystal structure of human placenta growth factor-1 (PlGF-1), an angiogenic protein, at 2.0 A resolution.血管生成蛋白人胎盘生长因子-1(PlGF-1)在2.0埃分辨率下的晶体结构。
J Biol Chem. 2001 Apr 13;276(15):12153-61. doi: 10.1074/jbc.M008055200. Epub 2000 Nov 7.

引用本文的文献

1
VEGF-A/VEGFR-1 signalling and chemotherapy-induced neuropathic pain: therapeutic potential of a novel anti-VEGFR-1 monoclonal antibody.VEGF-A/VEGFR-1 信号通路与化疗诱导的神经性疼痛:新型抗 VEGFR-1 单克隆抗体的治疗潜力。
J Exp Clin Cancer Res. 2021 Oct 14;40(1):320. doi: 10.1186/s13046-021-02127-x.
2
Arg-Leu-Tyr-Glu tetrapeptide inhibits tumor progression by suppressing angiogenesis and vascular permeability via VEGF receptor-2 antagonism.精氨酸-亮氨酸-酪氨酸-谷氨酸四肽通过拮抗血管内皮生长因子受体-2抑制血管生成和血管通透性,从而抑制肿瘤进展。
Oncotarget. 2017 Feb 14;8(7):11763-11777. doi: 10.18632/oncotarget.14343.
3
Vascular endothelial growth factor A: just one of multiple mechanisms for sex-specific vascular development within the testis?
血管内皮生长因子A:它只是睾丸内性别特异性血管发育的多种机制之一吗?
J Endocrinol. 2015 Nov;227(2):R31-50. doi: 10.1530/JOE-15-0342. Epub 2015 Oct 15.
4
Platelet-derived growth factors and their receptors: structural and functional perspectives.血小板衍生生长因子及其受体:结构与功能视角
Biochim Biophys Acta. 2013 Oct;1834(10):2176-86. doi: 10.1016/j.bbapap.2012.10.015. Epub 2012 Nov 5.
5
The discovery of placenta growth factor and its biological activity.胎盘生长因子的发现及其生物学活性。
Exp Mol Med. 2012 Jan 31;44(1):1-9. doi: 10.3858/emm.2012.44.1.025.
6
Tying the knot: the cystine signature and molecular-recognition processes of the vascular endothelial growth factor family of angiogenic cytokines.结扎:胱氨酸特征和血管内皮生长因子家族血管生成细胞因子的分子识别过程。
FEBS J. 2011 Nov;278(22):4304-22. doi: 10.1111/j.1742-4658.2011.08350.x. Epub 2011 Oct 7.
7
VEGF receptor signaling in vertebrate development.血管内皮生长因子受体信号在脊椎动物发育中的作用。
Organogenesis. 2010 Apr-Jun;6(2):97-106. doi: 10.4161/org.6.2.11686.
8
Structural insights into the binding of vascular endothelial growth factor-B by VEGFR-1(D2): recognition and specificity.血管内皮生长因子-B 与 VEGFR-1(D2)结合的结构见解:识别与特异性。
J Biol Chem. 2010 Jul 30;285(31):23779-89. doi: 10.1074/jbc.M110.130658. Epub 2010 May 25.
9
Structural determinants of growth factor binding and specificity by VEGF receptor 2.VEGF 受体 2 结合和特异性的结构决定因素。
Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2425-30. doi: 10.1073/pnas.0914318107.
10
Novel anti-VEGF chimeric molecules delivered by AAV vectors for inhibition of retinal neovascularization.通过腺相关病毒载体递送的新型抗血管内皮生长因子嵌合分子用于抑制视网膜新生血管形成。
Gene Ther. 2009 Jan;16(1):10-6. doi: 10.1038/gt.2008.115. Epub 2008 Jul 17.